Related Videos

  1. Will Life Sciences Firms Fall Off the Fiscal Cliff?

    Thu, 30 Aug 2012

    Even if the NIH is drastically cut, we don't see a doomsday scenario for these companies, and some of the industry's stronger players are now trading at attractive valuations.

  2. Smarter International Investing

    Sun, 7 Apr 2013

    Morningstar's Patty Oey and Dan Rohr and Columbia Acorn's Andreas Waldburg-Wolfegg offer best practices for globe-trotting investors who must navigate choppy waters in today's market.

Content Partners